It is a pharma private limited company based in Delhi, Delhi, India, established in 2020.
2020 | Delhi, Delhi, India | ActiveTorrvis Pharmaceuticals Private Limited, a active private limited company, was established on 11 December 2020 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233DL2020PTC374452. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Meenakshi Gupta (Director), Sanjay Gupta (Director). It holds ₹2.10 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No.302, Narmada Blk N-5, Sec-D, Pkt-6, Vasant Kunj,, Delhi, Delhi, 110070.
U24233DL2020PTC374452
374452
11 December 2020
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Torrvis Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Meenakshi Gupta | Director | 11 Dec 2020 | Current |
| Sanjay Gupta | Director | 11 Dec 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Torrvis Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 66.6% increase. The company also saw a substantial improvement in profitability, with a 12.21% increase in profit. The company's net worth Soared by an impressive increase of 55.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Torrvis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹21,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2023 | Hdfc Bank Limited | ₹2.10 Cr | Open |
Explore comprehensive loan charge details -
Torrvis Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Torrvis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Torrvis Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Torrvis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Torrvis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 21.00 M with Charge ID 100826078 was registered on 18 Sep 2023. was documented.
Progress on Meenakshi Gupta was appointed as a Director was appointed as a Director on 11 Dec 2020 & has been associated with this company since 4 years 11 months . was documented.
Sanjay Gupta was appointed as a Director was appointed as a Director on 11 Dec 2020 & has been associated with this company since 4 years 11 months . was recorded as a recent event.
The activity Torrvis Pharmaceuticals Private Limited was registered on 11 Dec 2020 with Roc Delhi & aged 4 years 11 months as per MCA records. was completed.
The CIN of Torrvis Pharmaceuticals Private Limited is U24233DL2020PTC374452.
Torrvis Pharmaceuticals Private Limited is headquartered at Flat No.302, Narmada Blk N-5, Sec-D, Pkt-6, Vasant Kunj,, Delhi, Delhi, 110070.
Torrvis Pharmaceuticals Private Limited was incorporated on 11 December 2020.
The current directors of Torrvis Pharmaceuticals Private Limited are
The primary industry of Torrvis Pharmaceuticals Private Limited is Manufacturing.
Torrvis Pharmaceuticals Private Limited is unlisted.
The authorized capital of Torrvis Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX